Inducible VEGF Expression by Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Reduces the Minimal Islet Mass Required to Reverse Diabetes

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hajizadeh Saffar, E ^a,b   Tahamtani, Y ^b   Aghdami, N ^b   Azadmanesh, K ^a   Habibi Anbouhi, M ^a   Heremans, Y ^c   De Leu, N ^c   Heimberg, H ^c   Ravassard, P ^d   Shokrgozar, M A ^a   Baharvand, H ^b,e  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c DIABETES RESEARCH CENTER   (Belgium)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL; BIOSYNTHESIS; CYTOLOGY; DIABETES MELLITUS; GENE EXPRESSION; GENETICS; HUMAN; HUMAN EMBRYONIC STEM CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOUSE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; TRANSPLANTATION;

ANIMALS; DIABETES MELLITUS; GENE EXPRESSION; HUMAN EMBRYONIC STEM CELLS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84926618526     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09322     Document Type: Article

References (53)

1. Cizza, G., Brown, R. J. & Rother, K. I. Rising incidence and challenges of childhood diabetes. A mini review. J Endocrinol Invest. 35, 541-546 (2012).
2. Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 343, 230-238 (2000).
3. Barton, F. B. et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 35, 1436-1445 (2012).
4. Brissova, M. & Powers, A. C. Revascularization of transplanted islets: can it be improved? Diabetes 57, 2269-2271 (2008).
5. Jansson, L. & Carlsson, P. O. Graft vascular function after transplantation of pancreatic islets. Diabetologia 45, 749-763 (2002).
6. Carlsson, P. O., Palm, F., Andersson, A. & Liss, P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50, 489-495 (2001).
7. Korsgren, O. et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 51, 227-232 (2008).
8. Henriksnas, J. et al. Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization. Diabetes 61, 665-673 (2012).
9. Kaufman-Francis, K., Koffler, J., Weinberg, N., Dor, Y. & Levenberg, S. Engineered vascular beds provide key signals to pancreatic hormone-producing cells. PloS One 7, e40741 (2012).
10. Ito, T. et al. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 89, 1438-1445 (2010).
11. Rackham, C. L. et al. Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia 54, 1127-1135 (2011).
12. Perez-Basterrechea, M., Obaya, A. J., Meana, A., Otero, J. & Esteban, M. M. Cooperation by fibroblasts and bonemarrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation. PloS One 8, e73526 (2013).
13. Berman, D. M. et al. Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes 59, 2558-2568 (2010).
14. Solari, M. G. et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J Autoimmun. 32, 116-124 (2009).
15. Sakata, N., Goto, M., Yoshimatsu, G., Egawa, S. & Unno, M. Utility of co-transplanting mesenchymal stem cells in islet transplantation. World J Gastroenterol. 17, 5150-5155 (2011).
16. Sordi, V. et al. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function. Stem Cells 28, 140-151 (2010).
17. Golocheikine, A. et al. Cooperative signaling for angiogenesis and neovascularization by VEGF and HGF following islet transplantation. Transplantation 90, 725-731 (2010).
18. Ding, Y. et al. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes 58, 1797-1806 (2009).
19. Semont, A. et al. Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration. PloS One 8, e70170 (2013).
20. Li, Z. et al. Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PloS One 6, e20526 (2011).
21. Kimbrel, E. A. et al. Mesenchymal Stem Cell Population Derived from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties. Stem Cells Dev. 23, 1611-1624 (2014).
22. Sigrist, S. et al. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant. 12, 627-635 (2003).
23. Cheng, Y., Liu, Y. F., Zhang, J. L., Li, T. M. & Zhao, N. Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. World J Gastroenterol. 13, 2862-2866 (2007).
24. Gupta, K. et al. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res. 247, 495-504 (1999).
25. Iwashita, N. et al. Impaired insulin secretion in vivo but enhanced insulin secretion from isolated islets in pancreatic beta cell-specific vascular endothelial growth factor-A knock-out mice. Diabetologia 50, 380-389 (2007).
26. Springer, M. L. et al. Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor. J Gene Med. 2, 279-288 (2000).
27. Lin, P., Correa, D., Lin, Y. & Caplan, A. I. Polybrene inhibits humanmesenchymal stem cell proliferation during lentiviral transduction. PloS One 6, e23891 (2011).
28. Shapiro, A. M. Strategies toward single-donor islets of Langerhans transplantation. Curr Opin Organ Transplant. 16, 627-631 (2011).
29. Jacobson, S., Kumagai-Braesch, M., Tibell, A., Svensson, M. & Flodstrom-Tullberg, M. Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts. Ann N Y Acad Sci. 1150, 213-216 (2008).
30. Brissova, M. et al. Pancreatic islet production of vascular endothelial growth factor - a is essential for islet vascularization, revascularization, and function. Diabetes 55, 2974-2985 (2006).
31. Biarnes, M. et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51, 66-72 (2002).
32. Phelps, E. A., Headen, D. M., Taylor, W. R., Thule, P. M. & Garcia, A. J. Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. Biomaterials 34, 4602-4611 (2013).
33. De Leu, N. et al. Short-term overexpression of VEGF-A in mouse beta cells indirectly stimulates their proliferation and protects against diabetes. Diabetologia 57, 140-147 (2014).
34. Korpisalo, P. et al. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy. Eur Heart J. 32, 1664-1672 (2011).
35. Mattsson, G., Jansson, L. & Carlsson, P. O. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51, 1362-1366 (2002).
36. Palfi, S. et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet 383, 1138-1146 (2014).
37. Aiuti, A. et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341, 1233151 (2013).
38. Biffi, A. et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341, 1233158 (2013).
39. Pepper, A. R., Gala-Lopez, B., Ziff, O. & Shapiro, A. M. Revascularization of transplanted pancreatic islets and role of the transplantation site. Clin Dev Immunol. 2013, 352315 (2013).
40. Vernon, R. B. et al. Reversal of diabetes in mice with a bioengineered islet implant incorporating a type I collagen hydrogel and sustained release of vascular endothelial growth factor. Cell Transplant 21, 2099-2110 (2012).
41. Barsotti, M. C. et al. Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif. 44, 33-48 (2011).
42. Cheng, J. Y., Raghunath, M., Whitelock, J. & Poole-Warren, L. Matrix components and scaffolds for sustained islet function. Tissue Eng Part B Rev. 17, 235-247 (2011).
43. Rowe, S. L. & Stegemann, J. P. Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios. Biomacromolecules 7, 2942-2948 (2006).
44. Lv, Q., Hu, K., Feng, Q. & Cui, F. Fibroin/collagen hybrid hydrogels with crosslinking method: preparation, properties, and cytocompatibility. J Biomed Mater Res A. 84, 198-207 (2008).
45. Rao, R. R., Peterson, A. W., Ceccarelli, J., Putnam, A. J. & Stegemann, J. P. Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis 15, 253-264 (2012).
46. Ye, Q. et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 17, 587-591 (2000).
47. Jalili, R. B. et al. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal. J Cell Physiol. 226, 1813-1819 (2011).
48. Kroon, M. E., van Schie, M. L., van der Vecht, B., van Hinsbergh, V. W. & Koolwijk, P. Collagen type 1 retards tube formation by human microvascular endothelial cells in a fibrin matrix. Angiogenesis 5, 257-265 (2002).
49. Brissova, M. et al. Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes beta cell regeneration. Cell Metab 19, 498-511 (2014).
50. Pakzad, M. et al. Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Rev. 6, 96-107 (2010).
51. Trivedi, P. & Hematti, P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol. 36, 350-359 (2008).
52. Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 52, 2745-2756 (1973).
53. Ricordi, C. et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat. 27, 185-195 (1990).